ATE536407T1 - Neuer tumormarker für pankreaskarzinom - Google Patents

Neuer tumormarker für pankreaskarzinom

Info

Publication number: ATE536407T1
Authority: AT; Austria
Prior art keywords: tumor marker; amino acid; pancreatic carcinoma; new tumor; fragment
Prior art date: 2007-07-25

Application number

AT08791487T

Other languages

English (en)

Inventor

Masaya Ono

Tesshi Yamada

Setsuo Hirohashi

Original Assignee

Japan Health Science Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-25

Filing date

2008-07-24

Publication date

2011-12-15

2008-07-24 Application filed by Japan Health Science Found filed Critical Japan Health Science Found

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE536407T1 publication Critical patent/ATE536407T1/de

Links

208000008443 pancreatic carcinoma Diseases 0.000 title abstract 2
239000000439 tumor marker Substances 0.000 title abstract 2
208000021045 exocrine pancreatic carcinoma Diseases 0.000 title 1
125000000539 amino acid group Chemical group 0.000 abstract 4
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 4
239000012634 fragment Substances 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 2
206010061902 Pancreatic neoplasm Diseases 0.000 abstract 1
229940012952 fibrinogen Drugs 0.000 abstract 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 abstract 1
201000002528 pancreatic cancer Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT08791487T 2007-07-25 2008-07-24 Neuer tumormarker für pankreaskarzinom ATE536407T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2007193328A JP5140809B2 (ja)	2007-07-25	2007-07-25	修飾α−フィブリノゲンタンパク質またはその免疫原性断片
PCT/JP2008/063235 WO2009014160A1 (ja)	2007-07-25	2008-07-24	膵癌の新規腫瘍マーカー

Publications (1)

Publication Number	Publication Date
ATE536407T1 true ATE536407T1 (de)	2011-12-15

Family

ID=40281408

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08791487T ATE536407T1 (de)	2007-07-25	2008-07-24	Neuer tumormarker für pankreaskarzinom

Country Status (5)

Country	Link
US (1)	US8017732B2 (de)
EP (1)	EP2182061B1 (de)
JP (1)	JP5140809B2 (de)
AT (1)	ATE536407T1 (de)
WO (1)	WO2009014160A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2009088022A1 (ja) *	2008-01-07	2011-05-26	国立大学法人鹿児島大学	新規癌マーカーおよびそれを用いた診断

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5200246B2 (ja) *	2005-03-14	2013-06-05	財団法人ヒューマンサイエンス振興財団	膵臓癌診断用マーカータンパク質
WO2006125021A2 (en) *	2005-05-16	2006-11-23	Dana Farber Cancer Institute, Inc.	Fibrinogen alpha and hemoglobin polypeptides as cancer markers
KR100679589B1 (ko)	2006-01-19	2007-02-06	삼성전자주식회사	포토레지스트 조성물 및 이를 이용한 포토레지스트 패턴의형성 방법

2007
- 2007-07-25 JP JP2007193328A patent/JP5140809B2/ja active Active
2008
- 2008-07-24 EP EP08791487A patent/EP2182061B1/de not_active Not-in-force
- 2008-07-24 AT AT08791487T patent/ATE536407T1/de active
- 2008-07-24 US US12/452,824 patent/US8017732B2/en not_active Expired - Fee Related
- 2008-07-24 WO PCT/JP2008/063235 patent/WO2009014160A1/ja not_active Ceased

Also Published As

Publication number	Publication date
EP2182061A4 (de)	2010-09-01
JP2009029731A (ja)	2009-02-12
JP5140809B2 (ja)	2013-02-13
EP2182061A1 (de)	2010-05-05
US8017732B2 (en)	2011-09-13
US20110112278A1 (en)	2011-05-12
EP2182061B1 (de)	2011-12-07
WO2009014160A1 (ja)	2009-01-29

Similar Documents

Publication	Publication Date	Title
SG10201804238TA (en)	2018-06-28	Enhanced deposition of chromogens utilizing pyrimidine analogs
EA200702278A1 (ru)	2008-08-29	Антитела, специфичные в отношении tgf-бета 1
PE20081250A1 (es)	2008-10-07	FUSIONES Fc CON RECEPTOR PARA FGF SOLUBLE MODIFICADAS, CON ACTIVIDAD BIOLOGICA MEJORADA
MY163480A (en)	2017-09-15	Sclerostin binding agents
GB0617429D0 (en)	2006-10-18	Markers of renal transplant rejection and renal damage
ATE491794T1 (de)	2011-01-15	Zusammensetzung und verfahren zur herstellung von steviolglykosiden
BRPI0513310A (pt)	2008-05-06	análogos de tetrapeptìdeo
MX2008010669A (es)	2008-09-03	Plantas con caracteristicas mejoradas y un metodo para prepararlas.
DK1831362T3 (da)	2012-01-09	Syreaktive svampeproteaser
ATE485517T1 (de)	2010-11-15	Verfahren zur identifizierung von polypeptid- targets
EA201001881A1 (ru)	2011-06-30	Пролинспецифичная протеаза из penicillium chrysogenum
ATE462000T1 (de)	2010-04-15	Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin
ATE517917T1 (de)	2011-08-15	Herstellung eines rekombinanten il-18-bindenden proteins
WO2009030770A3 (en)	2009-05-07	Methods and tools for prognosis of cancer in er- patients
ATE529445T1 (de)	2011-11-15	Biokinetik zur schnellen beseitigung von polypeptiden
EP1963506A4 (de)	2009-01-07	Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
DK1831239T5 (da)	2010-11-22	Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde
TW200716132A (en)	2007-05-01	Novel chemical compounds
EP2182061A4 (de)	2010-09-01	Neuer tumormarker für pankreaskarzinom
DE602006013109D1 (de)	2010-05-06	Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs
ATE466958T1 (de)	2010-05-15	Klassifizierung von kolonkrebs
EP2098594A4 (de)	2010-10-20	Nukleinsäuremolekül mit fähigkeit zur bindung an aus kaninchen stammenden igg-antikörper
ATE521626T1 (de)	2011-09-15	Fusionsprotein zur inhibierung von gebärmutterhalskrebs
ATE483730T1 (de)	2010-10-15	Bindungsfaktoren des insulin-like growth factor ii (igf-ii)
CY1109904T1 (el)	2014-09-10	Προαγωγεας της il-18bp, η παρασκευη και χρηση του